A 3-wk, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Phase 3b Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Immediate-release Tablets in the Treatment of Children and Adolescents With Bipolar I Mania (Abbreviated)
Phase of Trial: Phase III
Latest Information Update: 12 Apr 2013
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar I disorders
- Focus Registrational; Therapeutic Use
- Acronyms ANCHOR 149
- 02 Nov 2007 Status changed from recruiting to completed.
- 15 Oct 2005 New trial record.